Heartbeam, Inc. (BEAT) Dividend History
HeartBeam, Inc. (BEAT) is a healthcare technology company specializing in developing artificial intelligence-powered cardiovascular monitoring solutions. The company focuses on creating innovative, outpatient cardiac assessment tools that allow for early detection, diagnosis, and management of heart conditions, aiming to improve patient outcomes through advanced remote monitoring and analysis.
Phone: 408-899-4443
Website: https://www.heartbeam.com
Dividend History
Heartbeam, Inc. currently does not pay dividends
Company News
-
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program. FedEx reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $3.45 by 11.88% and represents a 13.2% increase over earnings of $3.41 per share from the same period last year. Quarterly sales came in at $21.7 billion, missing the analyst consensus estimate of $22.04 billion, according to data from Benzinga Pro. FedEx shares surged 12.4% to $297.72 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Murano Global Investments PLC (NASDAQ: MRNO) shares rose 266.4% to $35.43 in pre-market trading after falling 46% on Thursday. Nova LifeStyle, Inc. (NASDAQ: NVFY) rose 62.5% to $2.99 in pre-market trading after gaining around 22% on Thursday. BIOLASE, Inc. (NASDAQ: BIOL) shares rose 32.8% to $0.1990 in pre-market trading after the company ...
Benzinga -
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear. National CineMedia, Inc. (NASDAQ: NCMI) climbed 81% to $0.2409 after a 13G filing showed a 9.1% passive stake in the company from AMC Entertainment. IMAC Holdings, Inc. (NASDAQ: BACK) gained 71% to $0.2144. IMAC Holdings and Brain Scientific recently announced a strategic merger to create a synergistic end-to-end neurological solution. WW International, Inc. (NASDAQ: WW) shares jumped 48.9% to $6.14 after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $3.8 to $13. ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 47.4% to $2.44 after the company announced it partnered with Google Cloud to disrupt phishing attacks and malicious URLs. Clearmind Medicine Inc. (NASDAQ: CMND) gained 35.4% to $0.5818 after jumping more than 10% on Monday. Silvergate Capital Corporation (NYSE: SI) surged 33% to $1.85. Apollomics, Inc. (NASDAQ: APLM) jumped 30.5% to $10.62. Brookdale Senior Living Inc. (NYSE: BKD) shares gained 23.8% to $3.6899 after the company reported favorable updates to its Q1 financial expectations based upon preliminary, unaudited results. VBI Vaccines Inc. (NASDAQ: VBIV) jumped 23.8% to $0.1696. Nogin, Inc. (NASDAQ: NOGN) gained 22.6% to $2.17 following insider buying. BTCS Inc. (NASDAQ: BTCS) jumped 21.6% to $1.3871. Cognyte Software Ltd. (NASDAQ: CGNT) gained 21% to $4.14 after reporting upbeat Q4 results. SciSparc Ltd. (NASDAQ: SPRC) rose 17.2% to $0.5619. BigBear.ai Holdings, Inc. (NYSE: BBAI) gained 15% to $3.23. ReShape Lifesciences Inc. (NASDAQ: RSLS) jumped 14.5% to $3.0350. ...
Benzinga -
Upgrades For UDR Inc (NYSE:UDR), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, UDR showed an EPS of $0.60, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $61.06 and a 52-week-low of $37.18. At the end of the last trading period, UDR closed at $40.88. Canaccord Genuity upgraded the previous rating for The Toronto-Dominion Bank (NYSE:TD) from Hold to Buy. For the fourth quarter, Toronto-Dominion Bank had an EPS of $1.64, compared to year-ago quarter EPS of $1.66. The current stock performance of Toronto-Dominion Bank shows a 52-week-high of $86.02 and a 52-week-low of $57.27. Moreover, at the end of the last trading period, the closing price was at $68.37. See all analyst ratings upgrades. Downgrades China Renaissance downgraded the previous rating for XPeng Inc (NYSE:XPEV) from Buy to Hold. For the third quarter, XPeng had an EPS of $0.36, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $56.45 and a 52-week-low of $6.18. At the end of the last trading period, XPeng closed at $9.97. Canaccord Genuity downgraded the previous rating for Canadian Imperial Bank of Commerce (NYSE:CM) from Buy to Hold. Canadian Imperial Bank earned $1.05 in the fourth quarter, compared to $1.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $132.48 and a 52-week-low of $39.72. Canadian Imperial Bank closed at $44.53 at the end of the last trading period. Baird downgraded the previous rating for National Storage Affiliates Trust (NYSE:NSA) from Outperform to Neutral. For the third quarter, National Storage had an EPS of $0.72, compared to year-ago quarter EPS of $0.57. At the moment, the stock has a 52-week-high of $70.04 and a 52-week-low of $36.75. National Storage closed at $39.76 at the end of the last trading period. According to BMO Capital, the prior rating for Pebblebrook Hotel Trust (NYSE:PEB) was changed from Outperform to Market Perform. In the third quarter, Pebblebrook Hotel showed an EPS of $0.66, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $26.14 and a 52-week-low of $14.01. At the end of the last trading period, Pebblebrook Hotel closed at $16.61. For The Hain Celestial Group Inc (NASDAQ:HAIN), Evercore ISI Group downgraded the previous rating of Outperform to In-Line. For the first quarter, Hain Celestial Group had an EPS of $0.10, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $43.53 and a 52-week-low of $15.23. Hain Celestial Group closed at $18.74 at the end of the last trading period. Barclays downgraded the previous rating for Black Knight Inc (NYSE:BKI) from Overweight to Equal-Weight. Black Knight earned $0.56 in the third quarter, compared to $0.60 in the year-ago quarter. The current stock performance of Black Knight shows a 52-week-high of $84.27 and a 52-week-low of $52.00. Moreover, at the end of the last trading period, the closing price was at $61.95. Barclays downgraded the previous rating for Bright Horizons Family Solutions Inc (NYSE:BFAM) from Overweight to Equal-Weight. Bright Horizons Family earned $0.66 in the third quarter, compared to $0.64 in the year-ago quarter. The stock has a 52-week-high of $140.02 and a 52-week-low of $54.19. At the end of the last trading period, Bright Horizons Family closed at $74.84. For Ecolab Inc (NYSE:ECL), Barclays downgraded the previous rating of Overweight to Equal-Weight. Ecolab earned $1.30 in the third quarter, compared to $1.38 in the year-ago quarter. The current stock performance of Ecolab shows a 52-week-high of $237.38 and a 52-week-low of $131.04. Moreover, at the end of the last trading period, the closing price was at $151.94. According to Barclays, the prior rating for TransUnion (NYSE:TRU) was changed from Overweight to Equal-Weight. In the third quarter, TransUnion showed an EPS of $0.93, compared to $1.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $120.36 and a 52-week-low of $50.32. TransUnion closed at $62.47 at the end of the last trading period. According to Barclays, the prior rating for Blackstone Inc (NYSE:BX) was changed from Overweight to Equal-Weight. For the third quarter, Blackstone had an EPS of $1.06, compared to year-ago quarter EPS of $1.28. The current stock performance of Blackstone shows a 52-week-high of $146.04 and a 52-week-low of $79.55. Moreover, at the end of the last trading period, the closing price was at $85.04. According to Morgan Stanley, the prior rating for AvalonBay Communities Inc (NYSE:AVB) was changed from Overweight to Equal-Weight. For the third quarter, AvalonBay Communities had an EPS of $2.50, compared to year-ago quarter EPS of $2.06. At the moment, the stock has a 52-week-high of $259.05 and a 52-week-low of $158.35. AvalonBay Communities closed at $174.18 at the end of the last trading period. According to Oppenheimer, the prior rating for AppHarvest Inc (NASDAQ:APPH) was changed from Outperform to Perform. For the third quarter, AppHarvest had an EPS of $0.23, compared to year-ago quarter EPS of $0.17. The stock has a 52-week-high of $7.05 and a 52-week-low of $0.83. At the end of the last trading period, AppHarvest closed at $0.90. RBC Capital downgraded the previous rating for DoorDash Inc (NYSE:DASH) from Outperform to Sector Perform. For the third quarter, DoorDash had an EPS of $0.77, compared to year-ago quarter EPS of $0.30. The current stock performance of DoorDash shows a 52-week-high of $185.28 and a 52-week-low of $41.37. Moreover, at the end of the ...Full story available on Benzinga.com
Benzinga -
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) jumped 44.5% to close at $1.20. NeuroOne, last month, received FDA 510(k) clearance to market its Evo sEEG System for less than 30 day use. OncoSec Medical Incorporated (NASDAQ: ONCS) gained 42.2% to close at $4.85. OncoSec Medical recently announced early clinical data from an investigator-sponsored trial of TAVO in combination with Bristol-Myers Squibb’s intravenous Opdivo (nivolumab). Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) surged 40.3% to close at $2.47. NWTN Inc. (NASDAQ: NWTN) jumped 38.8% to close at $7.05. SeaStar Medical Holding Corporation (NASDAQ: ICU) shares jumped 33.6% to close at $5.25. Sotera Health Company (NASDAQ: SHC) gained 32.9% to close at $8.00. Barclays, last week, downgraded Sotera Health from Equal-Weight to Underweight and lowered the price target from $7 to $6. GrafTech International Ltd. (NYSE: EAF) climbed 31.3% to close at $5.54 after the company said it could resume operations at its Monterrey, Mexico facility. Charah Solutions, Inc. (NYSE: CHRA) rose 31.1% to close at $0.8777. Charah Solutions recently reported mixed Q3 results. uCloudlink Group Inc. (NASDAQ: UCL) gained 30.9% to settle at $3.47. The company recently posted a loss for the third quarter. Meta Materials Inc. (NASDAQ: MMAT) shares climbed 30.1% to close at $2.16 after dropping around 7% on Friday. HeartBeam, Inc. (NASDAQ: BEAT) gained 27.4% to settle at $4.04. HeartBeam recently announced that its patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended to detect heart attacks and complex cardiac arrhythmias was allowed by the United States Patent and Trademark Office (USPTO). Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) rose 26.3% to close at $1.44. Siyata Mobile Inc. (NASDAQ: SYTA) jumped 26.1% to close at $0.1942. Lannett Company, Inc. (NYSE: LCI) climbed 24.4% to close at $0.7401. Lannett recently posted Q1 adjusted loss of $0.42 per share. Drive Shack Inc. (NYSE: DS) gained 23.3% to settle at $0.44 after the company said Q3 EPS and sales results were higher year over year. Fusion Fuel Green PLC (NASDAQ: HTOO) jumped 23.2% to close at $4.51. Atento S.A. (NYSE: ATTO) gained 23.2% to close at $7.00. Companhia Paranaense de Energia – COPEL (NYSE: ELP) climbed 22.4% to close at $8.04. Cosmos Holdings Inc. (NASDAQ: COSM) jumped 21.2% to close at $0.1752 after jumping over 10% on Friday. Tenon Medical, Inc. (NASDAQ: TNON) gained 20.9% to close at $2.95. Tenon Medical recently posted a Q3 loss of $0.28 per share. Puma Biotechnology, Inc. ...
Benzinga -
Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the Fintel short squeeze leaderboard. Greenwich LifeSciences: Clinical stage biopharmaceutical company Greenwich LifeSciences (NASDAQ: GLSI) moved back up to the top of the Fintel short squeeze leaderboard after ranking third last week. Data showed 28.5% of the float short, up from last week’s 27.5% reported. The cost to borrow on shares is 11.1%, down slightly from last week’s 11.6% reported. Aerovate Therapeutics: Clinical stage biopharmaceutical company Aerovate Therapeutics (NASDAQ: AVTE) ...
Benzinga